Skip to main content

Beneficial ownership — 13D / 13G

87,240 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Xiaolin Zhang WNW Meiwu Technology Co Ltd 13G 7.67% 3y
Naiyun Bi WNW Meiwu Technology Co Ltd 13G 8.15% 3y
Huilin Xu WNW Meiwu Technology Co Ltd 13G 7.19% 3y
First Light Asset Management, LLC OFIX Orthofix Medical Inc. 13G/A 0.25% 3y
Adam London ASTR Astra Space, Inc. Class A Common Stock 13D/A 9.4% 3y
Chris Kemp ASTR Astra Space, Inc. Class A Common Stock 13D/A 9.3% 3y
GAMCO INVESTORS, INC. ET AL INVX Innovex International, Inc. 13D/A 5.73% 3y
Fund 1 Investments, LLC CTRN Citi Trends Inc 13D/A 11.37% 3y
Spear Catherine Eva FIGS FIGS, Inc. 13D/A 12.2% 3y
Philotimo Fund, LP OESX Orion Energy Systems, Inc. 13D/A 4.8% 3y
Hasson Heather L. FIGS FIGS, Inc. 13D/A 9.49% 3y
IMA Value LLP RAVE Rave Restaurant Group, Inc. 13D 5.33% 3y
White Lion Capital, LLC ACON Aclarion, Inc. 13G 5.9% 3y
Deep Track Capital, LP ABVX Abivax S.A. 13G 6.14% 3y
RA CAPITAL MANAGEMENT, L.P. MGNX Macrogenics Inc 13G 6.1% 3y
ELLINGTON MANAGEMENT GROUP LLC RPT Rithm Property Trust Inc. 13G 7.1% 3y
SUVRETTA CAPITAL MANAGEMENT, LLC ARQT Arcutis Biotherapeutics, Inc. 13G 9.99% 3y
HCG Opportunity, LLC CDAQF Compass Digital Acquisition Corp. 13D 36.4% 3y
Qiming U.S. Healthcare Fund II, L.P. TRML Tourmaline Bio, Inc. Common Stock 13D/A 3.2% 3y
Perception Capital Partners II LLC SPEC Spectaire Holdings, Inc. Common Stock 13D 59.6% 3y
Paradigm Biocapital Advisors LP NUVL Nuvalent, Inc. 13G 5.9% 3y
MOORE CAPITAL MANAGEMENT, LP EGOX Next.e.GO N.V. Ordinary Shares 13G 9.3% 3y
SUVRETTA CAPITAL MANAGEMENT, LLC ETNB 89bio, Inc. Common Stock 13G 6.4% 3y
Capital World Investors VNTR Venator Materials PLC 13D 18% 3y
Eureka Therapeutics, Inc. ESLA Estrella Immunopharma, Inc. 13D 71.8% 3y
Dan Wilks DWSN Dawson Geophysical Co 13D/A 80.03% 3y
Mark E. Strome ZIVO Zivo Bioscience, Inc. 13D/A 5.3% 3y
Rithm Capital Corp. SCU Sculptor Capital Management, Inc. Class A Common Stock 13D/A 12.8% 3y
Harraden Circle Investments, LLC ACBA Ace Global Business Acquisition Limited Ordinary Shares 13G 5.25% 3y
Murchinson Ltd. NNDM Nano Dimension Ltd. 13D/A 6.6% 3y
Steamboat Capital Partners, LLC WHLR Wheeler Real Estate Investment Trust, Inc. 13D/A 9.2% 3y
Sherborne Investors Management LP NAVI Navient Holdings, Inc. 13D/A 25% 3y
FJ Capital Management LLC BANC Banc Of California, Inc. 13G 5.02% 3y
Brookfield Oaktree Holdings, LLC GTX Garrett Motion Inc. 13D/A 13.9% 3y
Trevor Bezdek GDRX GoodRx Holdings, Inc. 13D/A 5.5% 3y
Douglas Joseph Hirsch GDRX GoodRx Holdings, Inc. 13D/A 5.5% 3y
Deep Track Capital, LP TRML Tourmaline Bio, Inc. Common Stock 13G 8.93% 3y
John Michael DiMaio MDAI Spectral AI, Inc. 13D 17.1% 3y
Steamboat Capital Partners, LLC WHLR Wheeler Real Estate Investment Trust, Inc. 13D/A 1.3% 3y
Pfizer Inc TRML Tourmaline Bio, Inc. Common Stock 13G 6.26% 3y
Commodore Capital LP NKTX Nkarta, Inc. 13G 5.6% 3y
GLAZER CAPITAL, LLC HCCI Heritage-Crystal Clean, Inc. 13G/A 0% 3y
272 Capital LP SQNS Sequans Communications 13D/A 18.5% 3y
Quogue Capital LLC IOVA Iovance Biotherapeutics, Inc. 13D/A 15.84% 3y
Cleveland Avenue Food and Beverage Fund II, LP PRST Presto Technologies, Inc. Common Stock 13D 17.3% 3y
CWAM LC Sponsor LLC LCW Learn CW Investment Corporation Class A Ordinary Shares 13D/A 42.8% 3y
SIT INVESTMENT ASSOCIATES INC CLM Cornerstone Strategic Investment Fund, Inc. 13G/A 4.68% 3y
Galloway Capital Partners, LLC WYY Widepoint Corp 13D 4.31% 3y
Lux Donn S. CASK Sempreon, Inc 13D/A 36.2% 3y
Silver Lake West HoldCo, L.P. EDR Endeavor Group Holdings, Inc. 13D/A 45.1% 3y